Health and Fitness Health and Fitness
Sun, June 7, 2009
Fri, June 5, 2009
Thu, June 4, 2009
Wed, June 3, 2009
Tue, June 2, 2009
Mon, June 1, 2009
Sat, May 30, 2009
Fri, May 29, 2009
Thu, May 28, 2009
Wed, May 27, 2009
Tue, May 26, 2009
Mon, May 25, 2009
Fri, May 22, 2009
Thu, May 21, 2009
Wed, May 20, 2009
Tue, May 19, 2009
Mon, May 18, 2009
Fri, May 15, 2009
Thu, May 14, 2009
Wed, May 13, 2009
Tue, May 12, 2009
Mon, May 11, 2009
Fri, May 8, 2009
Thu, May 7, 2009
Thu, April 16, 2009
Wed, April 15, 2009
Tue, April 14, 2009
Mon, April 13, 2009
Fri, April 10, 2009
Thu, April 9, 2009
Wed, April 8, 2009
Tue, April 7, 2009
Mon, April 6, 2009
Fri, April 3, 2009
Thu, April 2, 2009
Wed, April 1, 2009
Tue, March 31, 2009
Mon, March 30, 2009
Fri, March 27, 2009
Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009
Tue, March 17, 2009
Mon, March 16, 2009
Sun, March 15, 2009
Fri, March 13, 2009
Thu, March 12, 2009
Wed, March 11, 2009
Tue, March 10, 2009
Mon, March 9, 2009
Fri, March 6, 2009
Thu, March 5, 2009
Wed, March 4, 2009
Tue, March 3, 2009

Paradigm Medical Industries Inc.: Paradigm Medical Industries Signs LOI for Up to $1.8 Million in Structured Financing


//health-fitness.news-articles.net/content/2009/ .. r-up-to-1-8-million-in-structured-financing.html
Published in Health and Fitness on Tuesday, April 14th 2009 at 7:10 GMT, Last Modified on 2009-04-14 07:11:33 by Market Wire   Print publication without navigation


SALT LAKE CITY, UT--(Marketwire - April 14, 2009) - Paradigm Medical Industries, Inc. (OTCBB: [ PDMI ]) announced that on April 7, 2009 the Company signed a "Letter of Intent" (LOI) with Fairhills Capital for a structured financing of up to $1.8 million through the purchase of promissory notes from the Company. The LOI provides that $600,000 in notes will be purchased every three months over a nine month period, with the first purchase of $300,000 in notes to be made at closing and the remainder to be purchased upon the satisfaction of financial objectives to be mutually determined between the Company and Fairhills Capital.

Final details and contract for the financing are ongoing and expect to sign an agreement within the next ten days. Paradigm Medical will utilize the capital from the funding to re-launch and re-brand the Company in the global and domestic markets. Proceeds will be used for the development, redesign and upgrade to a number of their key products and to hire new key management and a sales team to help lead these efforts.

Fairhills Capital is a private equity firm that invests capital into companies in the emerging markets. The firm pursues investment opportunities in small-cap companies that have a strong management team and the ability to implement their business plan. Fairhills Capital has invested in over 50 public and private companies in various sectors including oil and gas, communication, arts and entertainment, services and medical sectors.

"The financing with Fairhills Capital is a major milestone for the Company," said Paradigm Medical's President, Stephen Davis. "With our new executive leadership, Paradigm is revitalized with a fresh, new sense of optimism and growth. We look forward to regaining the confidence of our shareholders as well as enhancing shareholder value."

About Paradigm Medical Industries, Inc.

Headquartered in Salt Lake City, UT, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

For more information, please visit: [ www.paradigm-medical.com ]

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.


Publication Contributing Sources